Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)
openRead the notice at vergabe-de ↗
Value
unstated
Published
30 Oct 2026
Deadline
—
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600DE501
Description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu dem Wirkstoff Rituximab (nur Fertigarzneimittel exklusive Darreichungsform zur subkutanen Injektion) zu schließen.
Key facts
- Reference
- OH-Biologika-2026-29
- Procedure
- open
- Lots
- 1
- Contact
- DZEM@tk.de+49 4069094-040
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- 33b69167-7e60-418e-8bf6-f90ebe8602a5
- OCID
- ocds-mnwr74-00ea26fa-f4b3-42b8-94d0-01142db753c1
- First seen
- 2 Nov 2026
- Last updated
- 2 Nov 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/87c6796c-4fe5-48fa-9a69-d0aca58ab6c0The source notice is authoritative — verify deadlines and documents there before bidding.